About Clarium
Clarium is a company based in New York (United States) founded in 2020 by Steve Liou. Clarium has raised $37.5 million across 2 funding rounds from investors including Ynhhs, General Catalyst and Kaiser Permanente Ventures. Clarium offers products and services including Astra OS, Disruption Monitoring, Substitute Management, and Procedure Card Optimization. Clarium operates in a competitive market with competitors including Global Healthcare Exchange, Bionexo, VPL, Jump Technologies and Curvo, among others.
- Headquarter New York, United States
- Founders Steve Liou
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$37.5 M (USD)
in 2 rounds
-
Latest Funding Round
$27 M (USD), Series A
May 08, 2025
-
Investors
Ynhhs
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clarium
Clarium offers a comprehensive portfolio of products and services, including Astra OS, Disruption Monitoring, Substitute Management, and Procedure Card Optimization.
Platform that unifies healthcare data for real-time insights and automation.
App for real-time inventory tracking and supply disruption detection.
Tool for automating substitute approvals and identifying equivalent products.
App that streamlines supply usage and minimizes waste in operations.
People of Clarium
Unlock access to complete
Unlock access to complete
Funding Insights of Clarium
Clarium has successfully raised a total of $37.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $27 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Clarium
Clarium has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Ynhhs, General Catalyst and Kaiser Permanente Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment and transformation services for entrepreneurs in technology and finance sectors.
|
Locked | Locked | Locked | |
|
Tech and Life Sciences focused corporate VC firm investing in the US
|
Locked | Locked | Locked | |
|
Early-stage Life-Sciences & Offline focused VC firm funding companies in the US
|
Locked | Locked | Locked |
Investor details for Clarium
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clarium
Investment portfolio details for Clarium
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Clarium
Detailed financials for Clarium
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clarium Comparisons
Peer comparison for Clarium
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Clarium
Clarium operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Global Healthcare Exchange, Bionexo, VPL, Jump Technologies and Curvo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Supply chain solutions for healthcare industry are provided.
|
|
| Locked | Locked | Locked |
Supply chain management solutions for hospitals
|
|
| Locked | Locked | Locked |
SaaS supply chain management software is provided for life sciences.
|
|
| Locked | Locked | Locked |
Supply chain management solutions are provided for the healthcare industry.
|
|
| Locked | Locked | Locked |
Cloud-based supply chain platforms are offered for healthcare organizations.
|
Detailed competitors of Clarium
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clarium
Complete news archive for Clarium
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clarium
Clarium was founded in 2020 and raised its 1st funding round 4 years after it was founded.
Clarium is headquartered in New York, United States. It is registered at New York, New York, United States.
Steve Liou is the current CEO of Clarium. They have also founded this company.
Clarium is a funded company, having raised a total of $37.5M across 2 funding rounds to date.
Clarium was founded in 2020 in New York, United States, by Steve Liou as founder and CEO. Operations focus on the healthcare sector, where a digital supply chain platform is provided to healthcare providers and suppliers. Real-time information exchange is facilitated through integration with existing systems, and efficiency is enhanced via artificial intelligence. Services target automation of supply chain processes in hospitals.
Clarium's top competitors include Global Healthcare Exchange, VPL and Bionexo.
Clarium offers Astra OS, Disruption Monitoring, Substitute Management, and Procedure Card Optimization.
Clarium has 8 investors. Key investors include Ynhhs, General Catalyst, Kaiser Permanente Ventures, TMC Venture Fund, and AlleyCorp.